Clinical Research in Cardiology

Article	Citations
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)	75
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients	70
Impact of the COVID-19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study	65
Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany	48
Mobile health solutions for atrial fibrillation detection and management: a systematic review	47
Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination	41
Physical activity, sedentary behavior and risk of coronary artery disease, myocardial infarction and ischemic stroke: a two-sample Mendelian randomization study	38
Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007–2017-insights from a national registry	38
The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes	38
Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study	36
Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials	35
Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside	35
Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario	34
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk	32
Estimated plasma volume status in heart failure: clinical implications and future directions	32
Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis	32
Machine learning in the detection and management of atrial fibrillation	31
Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis	30
Venting during venoarterial extracorporeal membrane oxygenation	28
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study	28
Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report	28
Outcome of patients treated with extracorporeal life support in cardiogenic shock complicating acute myocardial infarction: 1-year result from the ECLS-Shock study	28
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry	28
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	27
Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk	27

Concomitant tricuspid regurgitation severity and its secondary reduction determine long-term prognosis after transcatheter mitral valve edge-to-edge repair	27
Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis?	27
Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure	27
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study	25
Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM)	25
Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation	25
Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis	24
Colchicine in ischemic heart disease: the good, the bad and the ugly	24
Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data	23
Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013–2020	23
Effects of face masks on performance and cardiorespiratory response in well-trained athletes	23
Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patients	23
Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study	23
Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I	21
Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis	20
Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation	20
Heyde syndrome: prevalence and outcomes in patients undergoing transcatheter aortic valve implantation	20
Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry	20
Outcomes of conduction system pacing compared to right ventricular pacing as a primary strategy for treating bradyarrhythmia: systematic review and meta-analysis	20
Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolini	19
COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis	19
Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness	19
Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial	19
Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis	19
Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves	19
Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis	19
PASCAL versus MitraClip-XTR edge-to-edge device for the treatment of tricuspid regurgitation: a propensity-matched analysis	18
Timely and individualized heart failure management: need for implementation into the new guidelines	18
Reduction of permanent pacemaker implantation by using the cusp overlap technique in transcatheter aortic valve replacement: a meta-analysis	17
Global longitudinal strain improves risk assessment after ST-segment elevation myocardial infarction: a comparative prognostic evaluation of left ventricular functional parameters	17
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic	17
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia	16
CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy	16
Complications and mortality after catheter ablation of ventricular arrhythmias: risk in VT ablation (RIVA) score	16
PASCAL mitral valve repair system versus MitraClip: comparison of transcatheter edge-to-edge strategies in complex primary mitral regurgitation	16
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry	16
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial	15
Sex disparities and adverse cardiovascular and kidney outcomes in patients with chronic kidney disease: results from the KNOW-CKD	15
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry	15
Hemodynamics of self-expanding versus balloon-expandable transcatheter heart valves in relation to native aortic annulus anatomy	15
Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade	15
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome	15
Aortic valve replacement in Germany in 2019	14
Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging	14
Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials	14
Analysis of YouTube videos as a source of information for myocarditis during the COVID-19 pandemic	14
Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis	14
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry	14
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis	13
Expert opinion paper on cardiac imaging after ischemic stroke	13

Comorbidities complicating heart failure: changes over the last 15 years	13
Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?	13
Device-related risk of atrial fibrillation after closure of patent foramen ovale: a systematic review and meta-analysis	13
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure	13
TAVI in patients with low-flow low-gradient aortic stenosis–short-term and long-term outcomes	13
Long-term follow-up of patients undergoing renal sympathetic denervation	13
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry	13
Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)	13
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction	12
Heart rate variability and atrial fibrillation in the general population: a longitudinal and Mendelian randomization study	12
Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure	12
Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)	12
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction	12
Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort	12
Catheter ablation of short-coupled variant of torsade de pointes	12
Prognostic value of the chest X-ray in patients hospitalised for heart failure	12
Prospective blinded evaluation of smartphone-based ECG for differentiation of supraventricular tachycardia from inappropriate sinus tachycardia	11
“Get with the Guidelines Heart Failure Risk Score” for mortality prediction in patients undergoing MitraClip	11
Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair	11
Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study	11
Outcome of aortic stenosis according to invasive cardiac damage staging after transcatheter aortic valve replacement	11
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors	11
Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial	11
Echocardiography-derived total atrial conduction time (PA-TDI duration): risk stratification and guidance in atrial fibrillation management	11
Effects of the COVID-19 pandemic on acute coronary syndromes in Germany during the first wave: the COVID-19 collateral damage study	11
Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended	11
Real-world anticoagulatory treatment after percutaneous mitral valve repair using MitraClip: a retrospective, observational study on 1300 patients	11
Pregnancy-related acute myocardial infarction: a review of the recent literature	10
Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model	10
Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome	10
Impact of frailty on periprocedural health care utilization in patients undergoing transcatheter edge-to-edge mitral valve repair	10
The impact of epicardial adipose tissue in patients with acute myocardial infarction	10
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial	10
Cardiovascular profiling in the diabetic continuum: results from the population-based Gutenberg Health Study	10
Impact of early ablation of atrial fibrillation on long-term outcomes: results from phase II/III of the GLORIA-AF registry	10
Target and non-target vessel related events at 10 years post percutaneous coronary intervention	10
Iron deficiency and short-term adverse events in patients with decompensated heart failure	10
Quantitative flow ratio (QFR) identifies functional relevance of non-culprit lesions in coronary angiographies of patients with acute myocardial infarction	10
The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome	10
Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience	10
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities	10
High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany	10
Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus	10
Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction	10
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice	9
Commissural misalignment independently predicts leaflet thrombosis after transcatheter aortic valve implantation	9
Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials	9
Non-aortic cardiovascular disease in Marfan syndrome: a nationwide epidemiological study	9
Body fluid regulation via chronic inhibition of sodium–glucose cotransporter-2 in patients with heart failure: a post hoc analysis of the CANDLE trial	9
Validating real-time three-dimensional echocardiography against cardiac magnetic resonance, for the determination of ventricular mass, volume and ejection fraction: a meta-analysis	9
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis	9
Impact of pulse pressure on clinical outcome in extracorporeal cardiopulmonary resuscitation (eCPR) patients	9
Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial	9
Personalized diagnosis in suspected myocardial infarction	9
Echocardiographic diagnosis of atrial cardiomyopathy allows outcome prediction following pulmonary vein isolation	9
Heart rate variability: reference values and role for clinical profile and mortality in individuals with heart failure	9
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities	9
Diagnostic value of 18F-FDG PET/CT in infective endocarditis	9
Short- and long-term outcome of patients with spontaneous echo contrast or thrombus in the left atrial appendage in the era of the direct acting anticoagulants	9
Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials	9
Medical and cardio-vascular emergency department visits during the COVID-19 pandemic in 2020: is there a collateral damage? A retrospective routine data analysis	8
Cardiac autonomic function and cognitive performance in patients with atrial fibrillation	8
Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d’arrhythmies cardiaques)-group	8
Immunothrombosis and new-onset atrial fibrillation in the general population: the Rotterdam Study	8
Coronary artery disease, left ventricular function and cardiac biomarkers determine all-cause mortality in cancer patients—a large monocenter cohort study	8
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography	8
Effects of empagliflozin on left ventricular diastolic function in addition to usual care in individuals with type 2 diabetes mellitus—results from the randomized, double-blind, placebo-controlled EmD	8
How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance	8
Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018	8
Impact of effective regurgitant orifice area on outcome of secondary mitral regurgitation transcatheter repair	8
Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial	8
Clinical characteristics, causes and predictors of outcomes in patients with in-hospital cardiac arrest: results from the SURVIVE-ARREST study	8
Prediction of incident atrial fibrillation in post-stroke patients using machine learning: a French nationwide study	8
Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy	8
Propensity matched comparison of TAVI and SAVR in intermediate-risk patients with severe aortic stenosis and moderate-to-severe chronic kidney disease: a subgroup analysis from the German Aortic Valve	8
Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction	8
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation	8
Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity	7
Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR	7
Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)	7

The effects of positive end-expiratory pressure on cardiac function: a comparative echocardiography-conductance catheter study	7
Feasibility and effectiveness of a multidimensional post-discharge disease management programme for heart failure patients in clinical practice: the HerzMobil Tirol programme	7
Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation	7
Large-scale lipidomics profiling reveals characteristic lipid signatures associated with an increased cardiovascular risk	7
Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial	7
Comparison of contemporary transcatheter heart valve prostheses: data from the German Aortic Valve Registry (GARY)	7
Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany	7
Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020	7
Establishing a cardiac training group for patients with heart failure: the “HIP-in-Würzburg” study	7
New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis	7
Genetic and modifiable risk factors combine multiplicatively in common disease	7
COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany	7
TRI-SCORE is superior to EuroSCORE II and STS-Score in mortality prediction following transcatheter edge-to-edge tricuspid valve repair	7
Deferral of non-emergency cardiac procedures is associated with increased early emergency cardiovascular hospitalizations	7
Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials	7
Decreases in hepatokine Fetuin-A levels are associated with hepatic hypoperfusion and predict cardiac outcomes in patients with heart failure	7
In-hospital outcomes of self-expanding and balloon-expandable transcatheter heart valves in Germany	7
Very early infective endocarditis after transcatheter aortic valve replacement	6
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves	6
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019	6
Systematic review of renal denervation for the management of cardiac arrhythmias	6
Who is who in cardiovascular research? What a review of Nobel Prize nominations reveals about scientific trends	6
Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials	6
GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists	6
Minimally-invasive mitral valve repair of symmetric and asymmetric Barlow´s disease	6
German Cardiac Arrest Registry: rationale and design of G-CAR	6
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring	6
Drug overdose and the risk of cardiovascular diseases: a nested case–control study	6
Left ventricular function recovery after ST-elevation myocardial infarction: correlates and outcomes	6
Heart failure-related quality-of-life impairment after myocardial infarction	6
Impact of asymmetric tethering on outcomes after edge-to-edge mitral valve repair for secondary mitral regurgitation	6
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies	6
Drivers and recent trends of hospitalisation costs related to acute pulmonary embolism	6
Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany	6
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study	5
Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction	5
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial	5
CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in pati	5
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy	5
Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial	5
Pitfalls of the S-ICD therapy: experiences from a large tertiary centre	5
Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages	5
Nighttime hemodynamic phenotype. A novel risk factor for cardiovascular disease, especially heart failure: the practitioner-based nationwide JAMP study	5
Lack of correlation between different congestion markers in acute decompensated heart failure	5
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment	5
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial	5
Sinus heart rate post pulmonary vein ablation and long-term risk of recurrences	5
Imaging strategies for safety surveillance after renal artery denervation	5
A case of myocarditis in a 60-year-old man 48 h after mRNA vaccination against SARS-CoV2	5
Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy	5
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF	5
Prognostic impact of coronary chronic total occlusion on recurrences of ventricular tachyarrhythmias and ICD therapies	5
New challenges in cardiac intensive care units	5
Daily life and psychosocial functioning of adults with congenital heart disease: a 40–53 years after surgery follow-up study	5
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry	5
Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir	5
Contemporary incidence and predictors of left ventricular thrombus in patients with anterior acute myocardial infarction	5
Myocarditis mortality with and without COVID-19: insights from a national registry	5
Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management	5
A meta-analysis evaluating efficacy and safety of colchicine for prevention of major cardiovascular events in patients with coronary artery disease	5
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE	5
Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock	5
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial	5
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus	5
Association between stress hyperglycemia on admission and unfavorable neurological outcome in OHCA patients receiving ECPR	5
The Zwolle experience with left bundle branch area pacing using stylet-driven active fixation leads	5
Effects of acute alcohol consumption on cardiac excitation, conduction, and repolarization: results from the Munich Beer Related Electrocardiogram Workup Study (MunichBREW)	5
Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial	5
Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF	5
Activity of the adrenomedullin system to personalise post-discharge diuretic treatment in acute heart failure	5
Incidence and predictors of radial artery occlusion following transradial coronary angiography: the proRadial trial	5
Relationship between non-invasively detected liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome undergoing PCI	5
Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease	5
Stenting techniques for coronary bifurcation disease: a systematic review and network meta-analysis demonstrates superiority of double-kissing crush in complex lesions	5
Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease	5
Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart	5